Cholera kills 13 in southwest Haiti in wake of Matthew, dozens ill

A woman carries a child as they walk in front of destroyed houses after Hurricane Matthew passes JeremieBy Joseph Guyler Delva PORT-AU-PRINCE (Reuters) – Cholera outbreaks have killed at least 13 people in southwest Haiti in the wake of Hurricane Matthew, government officials told Reuters on Saturday, voicing concern that the disease was spreading. Six people died of Cholera in a hospital in the southern town of Randel, while another seven died in the western coastal town of Anse-d´Ainault, the officials said, likely as flood waters mixed with sewage. Cholera causes severe diarrhea and can kill within hours if untreated.

Go to Source

Hurricane Matthew death toll passes 800 in Haiti, cholera takes lives

Destroyed houses are seen in a village after Hurricane Matthew passes CorailBy Makini Brice and Joseph Guyler Delva CHANTAL, Haiti/PORT-AU-PRINCE (Reuters) – Hurricane Matthew&;s trail of destruction in Haiti stunned those emerging from the aftermath on Friday, with the number of dead soaring to 842, tens of thousands homeless and outbreaks of cholera already claiming more lives. Information trickled in from remote areas that were cut off by the storm, and it became clear that at least 175 people died in villages clustered among the hills and on the coast of Haiti&039;s fertile western tip. Food was scarce, and at least seven people died of cholera, likely because of flood water mixing with sewage.

Go to Source

Pfizer to sell infusion business to ICU Medical, take stake

The Pfizer logo is seen at their world headquarters in New YorkPfizer Inc said on Thursday it would sell its global infusion therapy business to ICU Medical Inc for $1 billion in cash and stock that will give it a major stake in the smaller company. Pfizer had acquired the hospital infusion system business, which has annual sales of about $1.2 billion, through its $15 billion purchase in September 2015 of Hospira, which sells generic hospital products and is developing biosimilars meant to compete with big-selling biotech drugs.

Go to Source

1 7 8 9 10 11